AGER and chronic myelogenous leukemia, BCR-ABL1 positive: Here, high CML-AGEs correlated with attenuated chemotherapeutic effects and aggressive behaviour of TNBCs, probably owing to their receptor (RAGE) activation eliciting chemo-resistance.